National Institutes of Health
HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)
HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional) is a funding opportunity from National Institutes of Health, closing September 7, 2027.
Overview
This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award to support milestone-driven research that advances innovative HIV prevention interventions from development and feasibility testing to larger-scale efficacy, effectiveness, implementation, and dissemination studies. The R61 phase will…